webinar register page

Webinar banner
What are the prospects – and limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth and proliferatio
Category: Pharma
> Solid Tumor Cancers

Theodore F. Search, MD
CEO, Skipta

> Mimi Huizinga, MD
Vice President and Head, US Oncology Medical, Novartis
> Dr. Marc Fellous
Global Medical Affairs Head, Bayer
> Sam Spigelman, MD
Senior Global Medical Affairs Leader, Janssen Research & Development, LLC
> Sabine Brookman-May, MD, PhD
Executive Medical Director, Late Development, Solid Tumor, Janssen Research & Development, LLC
> Ted W. Johnson, PhD
Research Fellow, Medicinal Chemistry, Pfizer Oncology, Pfizer Inc.
> Dr. Jorge Ortiz
Global Medical Affairs Head, Bayer
> Dr. Ute Simon
Head Global Medical Affairs, AAA ( a Novartis company)

Oct 28, 2020 12:30 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.